Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

FDA scaling for NTIDs [Design Issues]

posted by krishna – India, 2013-02-01 13:20 (4493 d 20:55 ago) – Posting: # 9941
Views: 7,631

Dear Helmut,

Many thanks for your explanation. I got the point.

Regards,
Krishna.

Complete thread:

NTIDs with high variability ioanam 2010-06-07 13:52 [Design Issues]
- NTIDs # HVDs (or not?) Helmut 2010-06-07 14:18
  - NTIDs # HVDs (or not?) ioanam 2010-06-07 18:17
    - Complicated ElMaestro 2010-06-07 18:28
  - NTIDs # HVDs (or not?) Dr_Dan 2010-06-08 12:24
    - Switch over Helmut 2010-06-08 12:34
      - NTIDs # HVDs (or not?) Relaxation 2010-06-09 22:38
        
        FDA scaling for NTIDs krishna 2013-01-07 14:01
        
        FDA scaling for NTIDs Helmut 2013-01-12 20:06
        
        FDA scaling for NTIDs krishna 2013-01-18 10:04
        
        FDA scaling for NTIDs Helmut 2013-01-20 12:46
        
        FDA scaling for NTIDskrishna 2013-02-01 12:20

Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
123 visitors (0 registered, 123 guests [including 56 identified bots]).
Forum time: 11:16 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body. Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz